Regulatory compliance in the pharmaceutical and biotechnology sectors is a complex, ever-evolving challenge. Companies face increasing scrutiny from global regulators, demanding precise documentation, risk management, and audit readiness. Traditional compliance methods often rely on manual processes that slow operations and increase the risk of errors. Modernizing compliance is no longer optional; it is essential for maintaining trust, avoiding costly penalties, and ensuring patient safety....